Title
P-Loop Conformation Governed Crizotinib Resistance In G2032r-Mutated Ros1 Tyrosine Kinase: Clues From Free Energy Landscape
Abstract
Tyrosine kinases are regarded as excellent targets for chemical drug therapy of carcinomas. However, under strong purifying selection, drug resistance usually occurs in the cancer cells within a short term. Many cases of drug resistance have been found to be associated with secondary mutations in drug target, which lead to the attenuated drug-target interactions. For example, recently, an acquired secondary mutation, G2032R, has been detected in the drug target, ROS1 tyrosine kinase, from a crizotinib-resistant patient, who responded poorly to crizotinib within a very short therapeutic term. It was supposed that the mutation was located at the solvent front and might hinder the drug binding. However, a different fact could be uncovered by the simulations reported in this study. Here, free energy surfaces were characterized by the drug-target distance and the phosphate-binding loop (P-loop) conformational change of the crizotinib-ROS1 complex through advanced molecular dynamics techniques, and it was revealed that the more rigid P-loop region in the G2032R-mutated ROS1 was primarily responsible for the crizotinib resistance, which on one hand, impaired the binding of crizotinib directly, and on the other hand, shortened the residence time induced by the flattened free energy surface. Therefore, both of the binding affinity and the drug residence time should be emphasized in rational drug design to overcome the kinase resistance.
Year
DOI
Venue
2014
10.1371/journal.pcbi.1003729
PLOS COMPUTATIONAL BIOLOGY
Keywords
Field
DocType
mutation,molecular dynamics simulation,binding sites,thermodynamics
Crizotinib,Drug design,Biology,Ligand (biochemistry),Drug resistance,Kinase,Bioinformatics,Genetics,ROS1,Mutation,Tyrosine kinase
Journal
Volume
Issue
ISSN
10
7
1553-7358
Citations 
PageRank 
References 
4
0.48
10
Authors
5
Name
Order
Citations
PageRank
Huiyong Sun1346.09
Youyong Li223818.54
Sheng Tian3333.67
Junmei Wang41290123.90
Tingjun Hou542754.50